Depakote
Product Images NDC 54868-5525

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 54868-5525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Depakote® Er Divalproex Sodium Extended-release Tablets 500 mg Package Label (4959)

Depakote® Er Divalproex Sodium Extended-release Tablets 500 mg Package Label (4959)
Depakote ER is a medication prescribed by physicians for total care. The package contains 6 tablets of 500mg each. The rest of the text is not available as it contains unreadable characters.*
FDA Label Image

Depakote® Er Divalproex Sodium Extended-release Tablets 250 mg Package Label (5525)

Depakote® Er Divalproex Sodium Extended-release Tablets 250 mg Package Label (5525)
FDA Label Image

Chemical Structure Of Divalproex Sodium (Depakote Er 01)

Chemical Structure Of Divalproex Sodium (Depakote Er 01)
FDA Label Image

Figure 3 (Depakote Er 02)

Figure 3 (Depakote Er 02)
FDA Label Image

Figure 1 (Depakote Er 03)

Figure 1 (Depakote Er 03)
The given text describes a graph or chart showing the percentage reduction in CPS (cycles per second) rate for patients taking Depakote compared to those taking placebo. The graph indicates a 100% reduction for Depakote and a 50% reduction for placebo. It also suggests an improvement in the condition of the patients taking Depakote.*
FDA Label Image

Figure 2 (Depakote Er 04)

Figure 2 (Depakote Er 04)
This text appears to be a chart showing the percentage reduction in CPS rate for High Dose DEPAKOTE vs. Low Dose DEPAKOTE. It also shows the percentage of patients who experienced improvement, no change, or worsening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.